CClinicalTrials.gg
Sign In
Status unknownNCT02292043Updated Nov 17, 2014

Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction

An observational study in Congestive Heart Failure, sponsored by Harbin Medical University. Status unknown at 2 sites in China. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-11-17.

Sponsored by Harbin Medical University · Observational

The sponsor has not verified this record recently (last verified Nov 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
60
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.

Read the detailed description

The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization would also calculated 3 months after discharge.

02

Conditions studied

  • Congestive Heart Failure
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 60 is below the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Harbin Medical University is the lead sponsor of 87 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

heart failure.

Inclusion criteria

  • 90 chronic cardiac failure patients in our hospital were selected and divided into two groups.

Exclusion criteria

Exclusion Criteria:

  • Vavular diseases
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • idiopathic dilated cardiomyopathy group

    idiopathic dilated cardiomyopathy group treated with HTEA

    Drug: HTEA

  • post-myocardial infarction group

    post-myocardial infarction group treated with TEA

    Drug: HTEA

Interventions

  • DrugHTEA

    HTEA

06

What researchers measure

Primary outcomes

  1. Morbidity

    Time frame: 1 months to 3 months after discharge

Secondary outcomes

  1. The decreased degree of NT-proBNP higher than 30%

    Time frame: 3 months after discharge

07

Study locations

2 of 2 sites recruiting
  • Ren Xiaohui
    Harbin, Heilongjiang 150001, China
    Recruiting
  • the first affiliated hospital of Harbin Medical University
    Harbin, Heilongjiang 150001, China
    • Xiaohui Ren · Contact · 86-451-85552320
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 17, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02292043
Lead sponsor
Harbin Medical University
Responsible party
Wei Liu (Prof. Liu, Harbin Medical University) — Principal investigator
First posted
Nov 17, 2014
Start date
May 2013
Primary completion
Jan 2015 (estimated)
Completion
Jan 2015 (estimated)
Last update
Nov 17, 2014

Study contacts

wei liu, Ph.D.
Contact
86-18904502999
xiaohui ren
Contact
86-451-85552320
wei liu
principal investigator · First Affiliated Hospital of Harbin Medical University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Heart Failure→

Other studies from this sponsor

Harbin Medical University

Start the discussion